Benefits of a prolonged-release amino acid mixture in four pregnant women with phenylketonuria
Nutrition and Health · 2025-04 · 31 (2) · 777-788
DOI: 10.1177/02601060241248522 ↗Kurz gefasst
Fallbericht in der Zeitschrift Nutrition and Health, online erschienen am 23.04.2024. Verfasst von Simona Sestito und 9 weiteren Autor:innen. Beteiligte Einrichtung: UOC Pediatria Specialistica e Malattie Rare, Università Magna Graecia, Catanzaro, Italy. Hauptthemen laut MEDLINE: Amino Acids, Dietary Supplements, Phenylketonuria, Maternal, Pregnancy Complications. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Background
Maternal phenylketonuria (mPKU) is a pathologic condition occurring in the fetus of a mother with PKU that is caused by prolonged elevated intrauterine blood phenylalanine (Phe) levels, which can lead to congenital abnormalities and mental retardation of newborns. Management of PKU during pregnancy can be challenging as protein substitutes may exacerbate nausea, vomiting, and gastrointestinal symptoms.
Aim
To report the successful management of four PKU pregnant women.
Methods
The patients were administered with prolonged-release amino acid supplementation and were recommended to follow a strict diet. Blood Phe concentration, adherence to diet, and occurrence of adverse events were monitored.
Results
All patients achieved safe levels of blood Phe concentration (120–360 µmol/L) since preconception and during pregnancy (mean Phe concentration values of 143.34 ± 137.59, 226.48 ± 194.57, 186.68 ± 133.67, and 187.47 ± 42.59 µmol/L). During the first trimester of pregnancy, all patients manifested gastrointestinal symptoms such as nausea, gastrointestinal reflux, and abdominal bloating, which were managed by either changing protein substitute or extending the time window between different meals and amino acid mixtures administration. The four women continued their pregnancies without experiencing further complications and delivered neonates with normal growth parameters and no malformations.
Conclusion
Findings of this case series suggest that the intake of a prolonged-release amino acid mixture in granules is well tolerated by pregnant PKU patients, eventually leading to good metabolic control and fetal growth within normal ranges.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UOC Pediatria Specialistica e Malattie Rare, Università Magna Graecia, Catanzaro, Italy.
- SSD Nutrizione Clinica e Metabolismo - IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
- Department of Metabolic Diseases, Clinical Genetics and Diabetology, Giovanni XXIII Children Hospital, Azienda Ospedaliero-Universitaria Consorziale, Bari, Italy.
ORCID-Profile: Michele Moretti, Albina Tummolo
Zitieren
APA
Sestito, S., Brodosi, L., Ferraro, S., Carella, R., De Giovanni, D., Mita, D., Moretti, M., Moricca, M. T., Concolino, D., & Tummolo, A. (2025). Benefits of a prolonged-release amino acid mixture in four pregnant women with phenylketonuria. Nutrition and Health, 31(2), 777-788. https://doi.org/10.1177/02601060241248522
Vancouver
Sestito S, Brodosi L, Ferraro S, Carella R, De Giovanni D, Mita D, et al. Benefits of a prolonged-release amino acid mixture in four pregnant women with phenylketonuria. Nutrition and Health. 2025;31(2):777-788. doi:10.1177/02601060241248522
BibTeX
@article{Sestito2025,
author = {Sestito, Simona and Brodosi, Lucia and Ferraro, Stefania and Carella, Rosa and De Giovanni, Donatella and Mita, Dorina and Moretti, Michele and Moricca, Maria Teresa and Concolino, Daniela and Tummolo, Albina},
title = {Benefits of a prolonged-release amino acid mixture in four pregnant women with phenylketonuria},
journal = {Nutrition and Health},
year = {2025},
volume = {31},
number = {2},
pages = {777--788},
doi = {10.1177/02601060241248522}
}
EUVIMED